The diagnosis, risk-stratification, and management of PCLs have relied heavily on qualitative imaging characteristics and endoscopic ultrasound (EUS) with cyst fluid analysis (cytology, carcinoembryonic antigen [CEA], and amylase level) as a standard of care [5,6,7]. The gene discussed is CEACAM5; the disease is cyst.